Vectofusin-1–based T-cell transduction approach compared with RetroNectin-based transduction for generating murine chimeric antigen receptor T-cells
Romil Patel(The University of Texas MD Anderson Cancer Center), Neeraj Saini(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
|Nature Medicine|2023|226
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma
|Blood Cancer Discovery|2022|72
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study
|Journal of Hematology & Oncology|2023|52